Bristol Myers Squibb buys Nvidia AI system for drug discovery
Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and…
Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and…
Enterprises evaluating Chinese open-weight models this month face a question that has nothing to do with benchmarks: whether using one will still be straightforward in a…
Public health departments across the United States will test generative AI tools under a new programme involving the Coalition for Health AI, OpenAI, Anthropic, and Accenture.…
Moonshot AI’s Kimi K3 open-weight model has been read almost entirely through its parameter count since it launchedon July 16. At 2.8 trillion parameters, it is…
Bunkerhill Health has raised $55 million to scale its agentic AI platform, Carebricks. The closing of the company’s Series B round, announced today, folds in continued…
Google DeepMind and Isomorphic Labs outlined a bioresilience program to curb AI misuse in biology while aiding outbreak response. The two organisations published an update on…
Neko Health has raised $700 million to expand its AI body scans in the United States, starting with a clinic in New York. The company’s preventive…
Nokia’s AI-RAN platform arrived on July 15 with a claim worth examining: that it is the industry’s first. The vendor says the platform, built on its…
AWS (Amazon Web Services) has explained how Bluesight developed Prism, an AI layer that connects hospital pharmacy and compliance data across its product suite. Prism Assistant…
AI agent crawlers, the bots that fetch pages in real time on behalf of a person waiting for an answer, will be blocked by default on…